Cargando…
Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
Hereditary angioedema (HAE), a rare autosomal dominant genetic disorder, is caused by a deficiency in functional C1 esterase inhibitor (C1-INH). This potentially life-threatening condition manifests as recurrent attacks of subcutaneous and submucosal swelling of the skin, gastrointestinal tract and...
Autor principal: | Riedl, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488495/ https://www.ncbi.nlm.nih.gov/pubmed/26091744 http://dx.doi.org/10.1007/s40261-015-0300-z |
Ejemplares similares
-
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
por: Reshef, Avner, et al.
Publicado: (2019) -
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021) -
Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance
por: Li, Huamin Henry
Publicado: (2016) -
Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor
por: Jones, Douglas, et al.
Publicado: (2023) -
Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2023)